Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Teva
Merck
UBS
Fish and Richardson
Deloitte
Boehringer Ingelheim
Argus Health

Generated: October 23, 2018

DrugPatentWatch Database Preview

HIPREX Drug Profile

« Back to Dashboard

When do Hiprex patents expire, and what generic alternatives are available?

Hiprex is a drug marketed by Us Pharm Holdings and is included in one NDA.

The generic ingredient in HIPREX is methenamine hippurate. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the methenamine hippurate profile page.

Drug patent expirations by year for HIPREX
Medical Subject Heading (MeSH) Categories for HIPREX
Synonyms for HIPREX
1,3,5,7-TETRAAZATRICYCLO[3.3.1.1(3),?]DECANE; 2-(PHENYLFORMAMIDO)ACETIC ACID
1,3,5,7-Tetraazatricyclo[3.3.1.13,7]decane N-Benzoylglycine
5714-73-8
714M738
AC1L2JF7
API0009010
C9H9NO3.C6H12N4
CHEBI:6825
CHEMBL1201104
D00855
EINECS 227-206-5
FT-0671059
Glycine, N-benzoyl, compd. with 1,3,5,7-tetraazatricyclo(3.3.1.1(sup 3,7))decane (1:1)
Haiprex
Hexamethylene tetramine hippurate
Hexamethylenetetramine hippurate
Hexamethylenetetramine monohippurate
Hexamethylenetetramine monohippurate;Hexamethylenetetramine monohippurate
hexamine hippurate
Hippramine
HIPPURIC ACID, compd. with HEXAMETHYLENETETRAMINE (1:1)
Hiprex (TN)
LS-75816
M329791L57
Methenamine hippurate
METHENAMINE HIPPURATE (200 MG)
Methenamine hippurate (JAN/USP)
Methenamine hippurate [USAN:USP:INN:BAN]
Methenamine hippurate [USAN]
Methenaminehippurate
N-Benzoylglycine, compound with 1,3,5,7-tetraazatricyclo(3.3.1.13,7)decane (1:1)
PL005986
R-657
SCHEMBL3029
UNII-M329791L57
Viapta

US Patents and Regulatory Information for HIPREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharm Holdings HIPREX methenamine hippurate TABLET;ORAL 017681-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Teva
Merck
UBS
Fish and Richardson
Deloitte
Boehringer Ingelheim
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.